Update Nov Dec 2013 - (Page 40)

FDLI Activities A Look Back at Advertising and Promotion 2013: Highlights from the Question and Answer Session with FDA Medical Product Center Representatives By Rachael A. Vieder, Manager, Medical Devices/Drugs Portfolio; Editor Photography from FDLI's 2013 Advertising and Promotion Conference by Valter Schleder J anet Lucy Rose, President, Lucy Rose & Associates, LLC, fired off audience inquiries to FDA product center representatives to close out the first day of the conference. Returning to the stage were CDER's Thomas W. Abrams, Director, Office of Prescription Drug Promotion, CBER's Lisa L. Stockbridge, PhD, Branch Chief, Advertising and Promotional Labeling Branch, Division of Case Management, Office of Compliance and Biologics Quality, CVM's 40 Update November/December 2013 Thomas Moskal, DVM, Dipl. ACLAM, MLIS, Veterinary Medical Officer, Post-Approval Review Team, Division of Surveillance and CDRH's Deborah Wolf, Regulatory Counsel, Office of Compliance. Wolf addressed questions on the changing internal structure of CDRH. Wolf clarified that the advertising and promotional policy staff was not made into division level per se, but were instead being shifted into the reorganized divisions. She said www.fdli.org http://www.fdli.org

Table of Contents for the Digital Edition of Update Nov Dec 2013

Update Nov Dec 2013